Condition: Atrial Fibrillation · Sponsor: Tulane University
The aim of the Correlation Of CoAGulation-Atrial Fibrillation (COAG-AF) study is to prove that an increase in pro-thrombotic biomarkers in AF is associated with an increase in AF burden. Secondary objectives of the study are the following: * To investigate the impact of catheter ablation on serum pro-thrombotic biomarkers in patients with AF. * To correlate coagulation biomarkers with imaging features such as, the degree of fibrosis found on Late Gadolinium Enhancement Magnetic Resonance Imaging (LGE-MRI) scans, which is a part of standard of care. * To determine baseline values of coagulation and pro-thrombotic biomarkers in the AF population and compare those baseline values with the general population values. * To compare central and peripheral thrombotic biomarkers in patients with atrial fibrillation.
This description comes directly from the study's public registry record.
Mayana Bsoul, MD · 504-988-3063 · mbsoul@tulane.edu
Kunal Sameer, MD, MHA · 504-988-3072 · ksameer@tulane.edu
Always discuss trial participation with your own doctor first.
| East Jefferson General Hospital | New Orleans, Louisiana, United States | Recruiting |
| University Medical Center | New Orleans, Louisiana, United States | Recruiting |
| Tulane Doctors - Speciality Care - Napoleon | New Orleans, Louisiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04947657